Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

257
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
257
Depressants01:28

Depressants

114
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
114
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

351
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
351
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

257
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
257
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

240
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
240
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effects of Fomepizole on Acetaminophen Oxidative Metabolism: A Randomized, Crossover Study in Human Volunteers.

Clinical pharmacology and therapeutics·2026
Same author

A prospective series of acute rivaroxaban overdose, coagulopathy and bleeding complications (ATOM 11).

British journal of clinical pharmacology·2026
Same author

Disentangling the role of environmental factors in the CKDu epidemic.

Nature reviews. Nephrology·2026
Same author

A Review of 3 Years of Cardiac Arrest Phone Calls to a State-Based Poisons Centre.

Emergency medicine Australasia : EMA·2026
Same author

Use of Point-of-Care Ultrasound During Cardiac Arrest in the Emergency Department: A Multicentre Retrospective Study.

Emergency medicine Australasia : EMA·2026
Same author

A qualitative study on utilization of vulnerability assessment tool for heatwave-related health adaptation intervention in Australia.

Health promotion international·2025

相关实验视频

Updated: Jun 27, 2025

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
11:05

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients

Published on: February 6, 2021

14.7K

在过量服用镇静剂后的认知障碍.

Patrick T Stewart1,2, Md Bayzidur Rahman3,4, Angela L Chiew1,5

  • 1Prince of Wales Hospital Clinical Toxicology Unit, Sydney, NSW, Australia.

Clinical toxicology (Philadelphia, Pa.)
|April 29, 2024
PubMed
概括

过量服用镇静剂的患者在医疗清除后表现出认知障碍,影响高风险活动. 道制作测试揭示了缺陷,建议在释放前谨慎使用.

关键词:
镇静剂 镇静剂是一种镇静剂.中枢神经系统抑郁剂 中枢神经系统抑郁剂认知障碍是一种认知障碍.过量的药物过量.这是一种中毒,中毒.步道制造试验试验 步道制造试验

更多相关视频

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

7.6K
Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
09:49

Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury

Published on: January 20, 2023

3.2K

相关实验视频

Last Updated: Jun 27, 2025

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
11:05

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients

Published on: February 6, 2021

14.7K
Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

7.6K
Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
09:49

Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury

Published on: January 20, 2023

3.2K

科学领域:

  • 神经科学是一个神经科学.
  • 毒理学 毒理学 毒理学
  • 紧急医疗 紧急医疗

背景情况:

  • 过量服用镇静剂可能导致残留的认知障碍,可能会影响出院后的患者安全.
  • 驾驶等高风险活动可能会因未被发现的认知缺陷而受到损害.
  • 步道测试 (TMT) 是一种用于评估认知功能的床边工具.

研究的目的:

  • 为了研究在服用镇静剂后医疗清除的患者的认知功能差异,与非镇静剂药物过量相比.
  • 评估Trail Making测试在识别过量后认知障碍方面的有用性.

主要方法:

  • 2018年至2021年期间进行的一项前性观察性研究.
  • 171名药物过量患者 (≥16岁) 在医疗许可后完成了Trail Making测试.
  • 统计分析包括t测试,曼-惠特尼U测试和后勤回归.

主要成果:

  • 与非镇静剂过量患者相比,服用镇静剂过量患者 (n=111) 在TMT A 部分和 B 部分的表现明显差.
  • 年龄较大和感知恢复较低与缓慢的TMT Part B表现有关.
  • 过量服用镇静剂的患者入住重症监护室的几率更高.

结论:

  • 过量服用镇静剂与显著的认知缺陷有关,即使在医疗许可后.
  • 高级思维障碍可能比基本认知功能更明显.
  • 建议患者在出院后避免高风险活动至关重要,以尽量减少伤害.